videos

Focused on your needs, our specialists provide appropriate support for precision bioanalysis, and a full range of research services for a wide range of study types — working with you to accelerate development, meet your milestones, and ensure compliant, on-time regulatory submissions for your drug candidates.

At Altasciences, we maintain an unwavering focus on the welfare of the laboratory animals in our care. Our entire preclinical staff is trained in laboratory animal care and focused on animal welfare and environmental enrichment — embracing compassion, sensitivity, and adherence to regulatory guidelines.

Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives — working with you to leverage preclinical data in the design of the studies that take your programs through to proof of concept.

Leveraging decades of experience conducting safety assessment, Altasciences offers a full range of in vivo GLP and non-GLP preclinical evaluation studies in multiple species to thoroughly assess the safety profile of your molecules.

We are a forward-thinking, mid-size contract research organization, offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development including preclinical safety testing, clinical pharmacology, bioanalysis and research services.

Altasciences has significant experience in cannabis, nicotine and tobacco product studies, both in the U.S. and Canada. We are invited members of the CORESTA (Cooperation Center for Scientific Research Relative to Tobacco) subcommittee on Smoking Behavior and Biomarkers, where we actively contribute to white papers concerning the latest requirements for clinical pharmacology studies needed for regulatory submission.

Imagine partnering with a team that you trust and telling your story once. Imagine a world where everyone and every project is of equal importance. Just imagine…